Lastly, over-expression of E2F2 was significantly associated with poor prognosis of patients with HCC, demonstrating that BRD4-E2F2-cell cycle regulation circuit is a novel target in liver cancer. This evidence concerns the gene BRD4 and hepatocellular carcinoma.